Vontobel Holding’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-120,000
| Closed | -$29.6K | – | 1538 |
|
|
2026
Q1 | $29.6K | Buy |
120,000
+50,000
| +71% | +$19.9K | ﹤0.01% | 1182 |
|
|
2025
Q4 | $29.4K | Sell |
70,000
-33,300
| -32% | -$17.7K | ﹤0.01% | 1421 |
|
|
2025
Q3 | $69.6K | Buy |
103,300
+30,000
| +41% | +$16.2K | ﹤0.01% | 1310 |
|
|
2025
Q2 | $39.7K | Buy |
73,300
+15,000
| +26% | +$8.91K | ﹤0.01% | 1241 |
|
|
2025
Q1 | $38.2K | Sell |
58,300
-93,800
| -62% | -$99.3K | ﹤0.01% | 1072 |
|
|
2024
Q4 | $155K | Sell |
152,100
-147,900
| -49% | -$270K | ﹤0.01% | 1027 |
|
|
2024
Q3 | $259K | Buy |
300,000
+241,440
| +412% | +$177K | ﹤0.01% | 950 |
|
|
2024
Q2 | $21K | Hold |
58,560
| – | – | ﹤0.01% | 1061 |
|
|
2024
Q1 | $39.2K | Buy |
58,560
+18,000
| +44% | +$13.1K | ﹤0.01% | 1060 |
|
|
2023
Q4 | $22K | Buy |
40,560
+10,000
| +33% | +$4.61K | ﹤0.01% | 1086 |
|
|
2023
Q3 | $18.3K | Hold |
30,560
| – | – | ﹤0.01% | 1060 |
|
|
2023
Q2 | $39.7K | Sell |
30,560
-40,000
| -57% | -$54.7K | ﹤0.01% | 1080 |
|
|
2023
Q1 | $124K | Buy |
70,560
+6,000
| +9% | +$17.1K | ﹤0.01% | 1016 |
|
|
2022
Q4 | $203K | Buy |
64,560
+24,000
| +59% | +$93.1K | ﹤0.01% | 996 |
|
|
2022
Q3 | $199K | Buy |
40,560
+20,000
| +97% | +$103K | ﹤0.01% | 952 |
|
|
2022
Q2 | $85K | Hold |
20,560
| – | – | ﹤0.01% | 984 |
|
|
2022
Q1 | $119K | Hold |
20,560
| – | – | ﹤0.01% | 1030 |
|
|
2021
Q4 | $154K | Hold |
20,560
| – | – | ﹤0.01% | 1012 |
|
|
2021
Q3 | $185K | Hold |
20,560
| – | – | ﹤0.01% | 1046 |
|
|
2021
Q2 | $246K | Hold |
20,560
| – | – | ﹤0.01% | 985 |
|
|
2021
Q1 | $258K | Hold |
20,560
| – | – | ﹤0.01% | 857 |
|
|
2020
Q4 | $321K | Buy |
+20,560
| New | +$241K | ﹤0.01% | 785 |
|
Other funds holding SGMO
Vontobel Holding's SGMO Position: Q2 2026 in Review
Vontobel Holding sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 120,000 shares — an estimated $29.6K sold.
Vontobel Holding first reported a position in SGMO in Q4 2020 and held it in 22 quarters. The position peaked at $321K in Q4 2020. 2 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.
- Vontobel Holding reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
- Vontobel Holding sold 120,000 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $29.6K.
- Vontobel Holding first reported a position in SANGAMO THERAPEUTICS INC in Q4 2020 and held it in 22 quarters.
- Vontobel Holding's SANGAMO THERAPEUTICS INC position peaked at $321K in Q4 2020.
- 2 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.
Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.